Phase 3 study for people with Heart Disease
Recruiting Phase 3
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| Nightingale Research | Adelaide | SA | Recruiting |
| University of the Sunshine Coast (UniSC) Clinical Trials - Birtinya | Birtinya | QLD | Recruiting |
| Core Research Group | Brisbane | QLD | Not yet recruiting |
| Advara HeartCare - Burwood | Burwood | NSW | Recruiting |
| Advara HeartCare Joondalup | Joondalup | WA | Recruiting |
| Advara HeartCare Leabrook | Leabrook | SA | Recruiting |
| AIM Research | Merewether | NSW | Recruiting |
| Advara HeartCare - Mulgrave | Mulgrave | VIC | Not yet recruiting |
| USC Clinical Trials Brisbane (South Bank) | South Brisbane | QLD | Recruiting |
| Clinitrials | West Perth | WA | Recruiting |
voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Inclusion Criteria:
* Have an Lp(a) ≥175 nmol/L
* Have established cardiovascular (CV) disease or are at risk for a first CV event
* Have angiographic evidence of coronary artery disease on screening CCTA
* If taking lipid-lowering medications, inclusive of statins or prescription strength niacin and PCSK9 inhibitors, these should be stable for 8 weeks
Exclusion Criteria:
* Have had a major CV event less than 60 days before measurement of the Lp(a) level used for eligibility or uncontrolled high blood pressure at screening
* Have moderate to severe renal dysfunction
* Have severe heart failure
* Have a history of coronary artery bypass graft surgery (CABG)
* Have a planned coronary angiography, percutaneous coronary intervention (PCI), coronary artery bypass graft, or valvular intervention
* Have had a procedure to remove lipoproteins from the blood or received therapy specifically targeting Lp(a)
* Are unable to safely undergo CCTA due to medication intolerance, contrast allergies, or anatomical/technical factors
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 8 October 2026.
- This page last checked by Voxsanity: 15 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.